FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects

Clinical trial NCT03970122 · COMPLETED

Trial details

NCT number: NCT03970122
Sponsor: Goldfinch Bio, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2019-05-29
Primary completion: 2020-03-04
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.